Haemophilia: Medical Treatments
(asked on 29th October 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people who were in receipt of (a) factor VIII and (b) factor IX Extended Half Life (EHLs) products had that treatment removed for (i) clinical and (ii) non-clinical reasons in 2017-18.
This question was answered on 6th November 2018
NHS England does not collect or hold information on the number of patients who have switched from Factor VIII and Factor IX Extended Half Life products to other treatments for clinical or non-clinical reasons in 2017-18.